Who We Are | Division of Pulmonary, Critical Care, Allergy & Sleep Medicine

Dr. Andrew Goodwin is a pulmonary intensivist committed to improving the health and well-being of critically ill patients through patient-centered care and clinical and translational research. His clinical interests include the hemodynamic management of septic shock and ventilation strategies for ARDS as well as strategies to mitigate ICU delirium. He also performs translational research focused on the potential role that micro RNA play in the endothelial dysfunction of sepsis and ARDS. In particular, he and his collaborators are focused on identifying the role that circulating miRNA have on endothelial cell gene expression and function and their potential use as a therapeutic in these syndromes. Additionally, he investigates the impact of patient factors such as race and comorbidities as well as hospital factors such as location and size on the outcomes of critical illness. His long-range goal is to improve the outcomes of critically ill patients through new therapeutics and optimal bedside care.

Dr. Ennis James became interested in sarcoidosis as a pulmonary and critical care fellow at Virginia Commonwealth University and joined the pulmonary faculty at MUSC in 2015. Dr James currently serves as the Program Director for the Susan Pearlstine Sarcoidosis Center of Excellence, and strongly believes in its vision to improve the lives of sarcoidosis patients by providing coordinated, patient-focused multidisciplinary care and cutting edge sarcoidosis research. He is happy to see sarcoidosis patients with any type of organ involvement.

Associate Professor

Associate Professor

Associate Professor

Associate Professor

Fellowship: Pulmonary Critical Care Medicine, MUSC
Residency: Medical University of South Carolina
Medical School: Pennsylvania State University College of Medicine

Professor

Assistant Professor

Clinical Assistant Professor

Clinical Assistant Professor

Assistant Professor

Co-investigator;
Assistant Professor of Medicine

Assistant Professor

Clinical Sciences Research Pathway Leader: Patrick Flume, M.D., is a Professor and Endowed Chair in the Departments of Medicine and Pediatrics. Dr. Flume has a long history of success in performing and leading large clinical trials in cystic fibrosis, bronchiectasis, and non-tuberculous mycobacteria pulmonary infections. He is Director of the MUSC CF Center, Director of the MUSC Therapeutic Development Network (TDN) research site (consistently in the top three performing centers in the network), and has served as a site Principal Investigator in >100 multi-center clinical trials and as the overall PI in >10 trials including the Standardized Treatment of Pulmonary Exacerbations in CF (STOP Program) funded by the CF Foundation. He has led the Pulmonary Clinical Trials Program for the last 10 years, providing supervision to a program that manages an average of 50 active studies at any given time. Many of his prior trainees have continued onto successful research careers in CF.

Instructor, Department of Medicine

"Reflex Biomarker Testing to Increase Use of Targeted Therapies in Lung Cancer Proposed Didactic Course Of Study: Selected Courses"

Primary Mentor: Gerard Silvestri, M.D.
Secondary Mentor: Paul Nietert, Ph.D.

Co-investigator;
MUSC Director of Bronchoscopy and Interventional Pulmonology

Dr. Andrew Goodwin is a pulmonary intensivist committed to improving the health and well-being of critically ill patients through patient-centered care and clinical and translational research. His clinical interests include the hemodynamic management of septic shock and ventilation strategies for ARDS as well as strategies to mitigate ICU delirium. He also performs translational research focused on the potential role that micro RNA play in the endothelial dysfunction of sepsis and ARDS. In particular, he and his collaborators are focused on identifying the role that circulating miRNA have on endothelial cell gene expression and function and their potential use as a therapeutic in these syndromes. Additionally, he investigates the impact of patient factors such as race and comorbidities as well as hospital factors such as location and size on the outcomes of critical illness. His long-range goal is to improve the outcomes of critically ill patients through new therapeutics and optimal bedside care.

Assistant Professor

Professor

Dr. Ennis James became interested in sarcoidosis as a pulmonary and critical care fellow at Virginia Commonwealth University and joined the pulmonary faculty at MUSC in 2015. Dr James currently serves as the Program Director for the Susan Pearlstine Sarcoidosis Center of Excellence, and strongly believes in its vision to improve the lives of sarcoidosis patients by providing coordinated, patient-focused multidisciplinary care and cutting edge sarcoidosis research. He is happy to see sarcoidosis patients with any type of organ involvement.

Assistant
Professor

Associate Professor

Associate Professor

Assistant
Professor

Assistant Professor

Assistant
Professor

Assistant Professor

Professor

Professor

Pulmonary Critical Care

Professor

Assistant Professor

Assistant Professor

Clinical Professor

Director and Professor

Assistant Professor

Professor

Assistant
Professor

Division Operations Manager
driggejk@musc.edu
843-792-3167

Fellowship, Training, and Education Manager
frampto@musc.edu

Pulmonary Critical Care

Clinical Effectiveness and Efficiency Manager
hoffmmar@musc.edu
843-792-3979

Clinical Research Program Manager
jonesash@musc.edu
843-792-4349

Thoracic Oncology Research Program Manager
balassom@musc.edu
843-792-6696

Rare Lung Disease Research Program Manager
blantonm@musc.edu
843-792-8438